High Katherine A
SEC insider (Form 3/4/5 filer). CIK 0001631248. Director at INCYTE CORP (INCY) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in BOSTON, MA.
Companies High Katherine A has filed insider reports for
- INCYTE CORP (INCY): Director
- CRISPR Therapeutics AG (CRSP): Director
High Katherine A
CIK: 0001631248
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 8, 2026INCY
INCYTE CORP
AwardDirect1.6K shares- - Jun 5, 2026CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares- - Jun 10, 2025INCY
INCYTE CORP
AwardDirect2.5K shares- - Jun 5, 2025CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares-
1-4 of 4 transactions